Synonyms: | |
Status: | Phase 2 |
Entry Type: | Small molecule |
Molecule Category: | UNKNOWN |
UNII: | 9BJ85K1J8S |
InChI Key | PAWIYAYFNXQGAP-UHFFFAOYSA-N |
---|---|
Smile | |
InChI |
|
Property Name | Value |
---|---|
Molecular Formula | C21H26N6O2 |
Molecular Weight | 394.48 |
AlogP | 2.09 |
Hydrogen Bond Acceptor | 7.0 |
Hydrogen Bond Donor | 3.0 |
Number of Rotational Bond | 6.0 |
Polar Surface Area | 95.31 |
Molecular species | BASE |
Aromatic Rings | 3.0 |
Heavy Atoms | 29.0 |
Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
---|---|---|---|---|---|---|
Epigenetic regulator
Eraser
Histone deacetylase
HDAC class I
|
- | 0-4 | 23 | 0-7 | - | |
Epigenetic regulator
Eraser
Histone deacetylase
HDAC class IIa
|
- | 1-5 | 28 | 0-7 | - | |
Epigenetic regulator
Eraser
Histone deacetylase
HDAC class IIb
|
- | 1-40 | - | 0-4 | - | |
Epigenetic regulator
Eraser
Histone deacetylase
HDAC class IV
|
- | 0 | - | 0-1300 | - | |
Unclassified protein
|
- | 5-5 | - | - | - |
Mesh Heading | Maximum Phase | Mesh ID | Reference |
---|---|---|---|
Lymphoma, T-Cell, Cutaneous | 2 | D016410 | ClinicalTrials |
Ovarian Neoplasms | 2 | D010051 | ClinicalTrials |
Lymphoma | 1 | D008223 | ClinicalTrials |
Resources | Reference |
---|---|
CAS NUMBER | 875320-29-9 |
ChEBI | 94771 |
ChEMBL | CHEMBL2105763 |
DrugBank | DB12985 |
EPA CompTox | DTXSID90236376 |
FDA SRS | 9BJ85K1J8S |
Guide to Pharmacology | 7503 |
PDB | GOK |
PubChem | 11538455 |
SureChEMBL | SCHEMBL2360460 |
ZINC | ZINC000035836133 |